Feature Channels: Stem Cells

Filters close
Released: 10-Dec-2019 4:05 PM EST
病例报告:干细胞可加改善髓损伤后的运动和感觉功能
Mayo Clinic

Mayo Clinic的一项早期研究显示,源自患者自身脂肪的干细胞可进一步改善(而不仅是稳定)脊髓损伤患者的运动和感觉功能。

Released: 10-Dec-2019 4:05 PM EST
تقرير حالة: الخلايا الجذعية خطوة نحو تحسين الحركة والوظائف الحسية بعد إصابة الحبل النخاعي
Mayo Clinic

تقدم الخلايا الجذعية المأخوذة من دهون المريض خطوة نحو تحسين - وليس مجرد استقرار - في الحركة والوظائف الحسية لمن يعانون من إصابات في الحبل النخاعي، وذلك وفقًا لبحث أولي أجرته Mayo Clinic.

Released: 10-Dec-2019 11:35 AM EST
Mayo Clinic, W. L. Gore & Associates announce Avobis Bio, a joint venture for new regenerative therapies
Mayo Clinic

Mayo Clinic and W. L. Gore & Associates Inc., a global materials science company, have formed a joint venture to advance the development of implantable cell therapies to treat debilitating conditions with no cure. Avobis Bio will combine Mayo Clinic's clinical and cell expertise and Gore’s expertise in material sciences to address some of the most challenging medical issues.

6-Dec-2019 10:10 AM EST
New Mayo Clinic studies to be presented at American Society of Hematology meeting
Mayo Clinic

Mayo Clinic researchers will present findings at the American Society of Hematology Annual Meeting Dec. 7–10 in Orlando. New Mayo Clinic studies to be presented include: DNA analysis identifies elevated risk factor for myeloma in individuals of African ancestry Study identifies more precise assessment measures for patients newly diagnosed with chronic lymphocytic leukemia Researchers develop method to assess cancer-fighting cell therapy's effectiveness

26-Nov-2019 5:05 PM EST
Treatment with PD-1 inhibitor prior to stem cell transplant is safe, effective for patients with classic Hodgkin lymphoma, study finds
Dana-Farber Cancer Institute

A new analysis shows that a donor stem cell transplant following treatment with an immune checkpoint inhibitor is generally safe and produces good outcomes for patients with Hodgkin lymphoma.

5-Dec-2019 12:05 PM EST
Use of venetoclax in reduced-intensity transplant conditioning regimen in patients with high-risk myeloid cancers shows promise in early trial
Dana-Farber Cancer Institute

For patients with high-risk myeloid cancers undergoing a donor stem cell transplant, adding the targeted drug venetoclax to a reduced-intensity drug regimen prior to transplant is safe and does not impair the ability of the donor cells to take root in recipients’ bodies, a study led by Dana-Farber Cancer Institute researchers suggests.

Released: 5-Dec-2019 4:55 PM EST
Novel bioprinter shows potential to speed tissue engineering
University of Alabama at Birmingham

Researchers have found a way to speed engineered-tissue creation using a novel bioprinter built for $2,000, they report in the journal Micromachines. Building blocks for the tissue are pre-grown spheroids of human induced-pluripotent stem cells that contain 200,000 cells per spheroid.

Released: 5-Dec-2019 8:40 AM EST
What Does DNA’s Repair Shop Look Like? New Research Identifies the Tools
New York University

A team of scientists has identified how damaged DNA molecules are repaired inside the human genome, a discovery that offers new insights into how the body works to ensure its health and how it responds to diseases that stem from impaired DNA.

   
Released: 3-Dec-2019 3:10 PM EST
Study tests potential solution to male infertility
University of Georgia

Researchers from the University of Georgia, Emory University School of Medicine and the University of Pittsburgh have received a $2.9 million grant from the National Institutes of Health to test a novel method of producing viable sperm cells from skin cells.

Released: 3-Dec-2019 1:35 PM EST
Harvard Medical School Launches Project to Transform the Treatment of Pain
Harvard Medical School

DARPA-funded project called STOP PAIN aimed at the design of safer, more effective pain treatments Research to focus on understanding the biology of pain as a way to transform clinical care, help stem the public health crisis fueled by opioids Efforts will encompass expertise from fields including neurobiology, stem cell biology, artificial intelligence and computational and medicinal chemistry

Released: 2-Dec-2019 2:20 PM EST
Informe de caso: Células madre son un paso adelante en mejoramiento de funciones motoras y sensoriales después de lesión de la médula espinal
Mayo Clinic

Las células madre derivadas del propio tejido adiposo del paciente constituyen un paso adelante en el mejoramiento (no solo en la estabilización) de las funciones motoras y sensoriales después de una lesión de la médula espinal, informa uno de los primeros estudios sobre el tema realizado por Mayo Clinic.

Released: 27-Nov-2019 2:25 PM EST
Researchers identify protein that governs human blood stem cell self-renewal
University of California, Los Angeles (UCLA), Health Sciences

UCLA scientists have discovered a link between a protein and the ability of human blood stem cells to self-renew. In a study published today in the journal Nature, the team reports that activating the protein causes blood stem cells to self-renew at least twelvefold in laboratory conditions

24-Nov-2019 2:00 PM EST
Stem Cell Therapy Helps Broken Hearts Heal in Unexpected Way
Cincinnati Children's Hospital Medical Center

A study in Nature shows stem cell therapy helps hearts recover from a heart attack, although not for the biological reasons originally proposed two decades ago that today are the basis of ongoing clinical trials. The study reports that injecting living or even dead heart stem cells into the injured hearts of mice triggers an acute inflammatory process, which in turn generates a wound healing-like response to enhance the mechanical properties of the injured area.

Released: 27-Nov-2019 9:35 AM EST
Case report: Stem cells a step toward improving motor, sensory function after spinal cord injury
Mayo Clinic

Stem cells derived from a patient's own fat offer a step toward improving — not just stabilizing — motor and sensory function of people with spinal cord injuries, according to early research from Mayo Clinic.

Released: 25-Nov-2019 1:25 PM EST
Dana-Farber researchers to present more than 40 studies at 2019 ASH Annual Meeting
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute researchers will present more than 40 research studies at the 61st American Society of Hematology (ASH) Annual Meeting on December 7-10 in Orlando, Fla.

Released: 25-Nov-2019 10:40 AM EST
Mayo Clinic, Children's of Alabama announce rare congenital heart defect collaboration
Mayo Clinic

Mayo Clinic's Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) and Children's of Alabama announce their collaboration within a consortium to provide solutions for patients with hypoplastic left heart syndrome, a rare and complex form of congenital heart disease in which the left side of the heart is severely underdeveloped.

Released: 25-Nov-2019 6:00 AM EST
Intestinal Stem Cell Genes May Link Dietary Fat and Colon Cancer
Rutgers University-New Brunswick

Two genes that appear to help stem cells in the intestine burn dietary fat may play a role in colon cancer, according to a Rutgers study. The study, published in the journal Gastroenterology, describes a new connection between the way cells consume fat and how genes regulate stem cell behavior in the intestines of mice.

Released: 21-Nov-2019 3:20 PM EST
Fred Hutch at ASH: Latest CAR T data – BCMA, CD19, CD20 – plus new insights on transplantation, gene therapy – and more
Fred Hutchinson Cancer Center

The 61st American Society of Hematology Annual Meeting and Exposition will take place Dec. 7–10 in Orlando, Florida

Released: 14-Nov-2019 3:35 PM EST
Genetic Variation in Individual Brain Cell Types May Predict Disease Risk
UC San Diego Health

Researchers identified non-coding regions of the human genome that control the development and function of four brain cell types and mapped genetic risk variants for psychiatric diseases. They found that risk variants for Alzheimer’s disease were enriched in microglia-specific regulatory elements.

Released: 12-Nov-2019 5:30 AM EST
‘It’s not about just surviving. It’s about seeing my patients living normally’
University Health Network (UHN)

Dr. Eugene Chang was 25, recently engaged and halfway through a physical medicine and rehabilitation residency in Vancouver when he started feeling sick. Fatigue, dizziness and nausea took over his normally active lifestyle. Suddenly his bike to work was not so easy.



close
2.44526